As a treatment director with Minnesota Adult and Teen Challenge (MnTC), I oversee a 44-bed women’s addiction treatment ...

Central Valley leaders are asking voters to weigh in one of the oldest public policy questions: Which works better, the ...

This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in ...

Buprenorphine is relatively safe and reduces the risk of opioid death by 38% compared with those not receiving medication.

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

It's been one month since Oregon's new drug possession charge took affect and most counties have been operating a deflection ...

Rapamycin could counteract the harmful effects of Sodium Valproate, a common epilepsy medication, on fetal spinal cord development.

City officials found emergency workers were working at drug-treatment facility in non-emergency roles, violating state law.

Health department data show a 7% decrease from 2022 to 2023, reflecting national trends. But racial disparities remain high ...

Travis County Commissioners approved funding for a residential treatment program for women battling substance use disorder.

Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell ...